10월
21
2022
Roche Stock Rhhbf: Dominant Firm With A Powerful Oncology Business Enterprise
In November, the corporation inaugurated its new CHF 250-million (US$275-million) R&D developing. The facility focuses on investigation and improvement of pharmaceutical formulations for new active ingredients,...